![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Flow cytometry evaluation of acute myeloid leukemia minimal residual disease
based on an understanding of the normal maturation patterns in the blast
compartments.
Am J Clin Pathol. 2025 Feb 8:aqae187. doi: 10.1093.
PubMed
Abstract available
The Efficacy of Pediatric-Inspired Regimens vs. Hyper-CVAD in the Treatment of
Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Systematic
Review and Meta-Analysis.
Am J Hematol. 2025 Feb 13. doi: 10.1002/ajh.27607.
PubMed
Abstract available
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and
Management.
Am J Hematol. 2025 Feb 12. doi: 10.1002/ajh.27625.
PubMed
Abstract available
BCR::ABL1-Positive Acute Myeloid Leukemia.
Am J Hematol. 2025 Feb 11. doi: 10.1002/ajh.27633.
PubMed
Long-Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for
BCR::ABL1-Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective
Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for
Transplantation
Am J Hematol. 2025 Feb 11. doi: 10.1002/ajh.27641.
PubMed
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response
and Outcomes to Contemporary Therapies.
Am J Hematol. 2025 Feb 8. doi: 10.1002/ajh.27628.
PubMed
Abstract available
Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling
evidence on the role of IL3 overexpression in tumorigenesis.
Ann Hematol. 2025 Feb 9. doi: 10.1007/s00277-025-06217.
PubMed
Abstract available
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia:
HM-SCREEN-Japan 01 and 02 study.
Ann Hematol. 2025 Feb 8. doi: 10.1007/s00277-025-06227.
PubMed
Abstract available
European Myeloma Network Group Review and Consensus Statement on Primary Plasma
Cell Leukemia.
Ann Oncol. 2025 Feb 7:S0923-7534(25)00058-4. doi: 10.1016/j.annonc.2025.
PubMed
Abstract available
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome
antigen heterogeneity in AML.
Blood. 2025;145:720-731.
PubMed
Abstract available
Acute erythroid leukemia or acute myeloid leukemia with mutated TP53? The battle
of phenotype versus genotype.
Blood. 2025;145:784.
PubMed
Acute resistance to BET inhibitors remodels compensatory transcriptional programs
via p300 coactivation.
Blood. 2025;145:748-764.
PubMed
Abstract available
Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated
with specific subtypes and treatment outcome.
BMC Cancer. 2025;25:253.
PubMed
Abstract available
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid
leukemia patients undergoing stem cell transplantation with post-transplant
cyclophosphamide: a study from the acute leukemia working party of the EBMT.
Bone Marrow Transplant. 2025 Feb 12. doi: 10.1038/s41409-025-02527.
PubMed
Abstract available
Measurable residual disease testing and allogeneic hematopoietic cell
transplantation for AML: adapting Pre-MEASURE to clinical practice.
Bone Marrow Transplant. 2025;60:128-134.
PubMed
Abstract available
Precision medicine results from equitable representation.
Bone Marrow Transplant. 2025;60:122-127.
PubMed
Abstract available
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in
patients with FMS-like tyrosine kinase 3-internal tandem duplication acute
myeloid leukemia: A phase 2 study.
Cancer. 2025;131:e35746.
PubMed
Abstract available
Atypical Hairy Cell Leukemia-The Current Status and Future Directions.
Eur J Haematol. 2025 Feb 10. doi: 10.1111/ejh.14388.
PubMed
Abstract available
Development of a policy model for pediatric acute lymphoblastic leukemia to
facilitate economic evaluation.
J Natl Cancer Inst. 2025 Feb 14:djaf024. doi: 10.1093.
PubMed
Abstract available
Isolated CNS B lymphoid/myeloid bilineage relapse following allogeneic
hematopoietic stem cell transplantation in adult acute myeloid leukemia with
KMT2A::MLLT1 rearrangement.
Leuk Lymphoma. 2025 Feb 10:1-4. doi: 10.1080/10428194.2025.2460046.
PubMed
Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation
in T-prolymphocytic leukemia.
Leuk Lymphoma. 2025 Feb 8:1-4. doi: 10.1080/10428194.2025.2462950.
PubMed
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy
in combination with dasatinib in first line treatment of Philadelphia chromosome
positive acute lymphoblastic leukemia.
Leuk Lymphoma. 2025 Feb 8:1-9. doi: 10.1080/10428194.2025.2460737.
PubMed
Abstract available
Serum hypoalbuminemia is an independent prognostic factor in Chronic
Myelomonocytic Leukemia (CMML).
Leuk Res. 2025;150:107662.
PubMed
Abstract available
Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes
colorectal cancer through directly degrading a tumor suppressor promyelocytic
leukemia (PML).
Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
PubMed
Metabolomic insights into pathogenesis and therapeutic potential in adult acute
lymphoblastic leukemia.
Proc Natl Acad Sci U S A. 2025;122:e2423169122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.